August 31, 2018 | 1:51 PM by Fahad Khalid

Glaukos (GKOS) – iStent inject for Glaucoma

It pays to do fundamental research. This bullish view was first presented in the 3Q2018 Quarterly Outlook on July 1 with the stock at $40.65. The stock is now at…

Continue Reading »

January 5, 2018 | 12:49 PM by Fahad Khalid

Intersect ENT (XENT) Final Update – Closing Calls for +33% Gain

Please Subscribe or Login to access premium content.

December 7, 2017 | 2:15 PM by Fahad Khalid

Intersect ENT (XENT)

Please Subscribe or Login to access premium content.

May 29, 2017 | 10:27 AM by Fahad Khalid

Weekend Research – May 29

Please Subscribe or Login to access premium content.

Password must meet the following requirements: